Clinical Trials Logo
  1. Home
  2. Embryo Transfer
  3. NCT02257359

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers

Embryo Transfer Clinical Trial

Official title:
A Phase 1, Open Label, Ascending Cohort, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban and Its Metabolite in Healthy Female Volunteers Following Administration of Epelsiban

Clinical Trial Summary

Epelsiban is a potent and selective oxytocin receptor antagonist in development for enhanced implantation rates during in-vitro fertilization (IVF). This study a non-randomized, open label study designed to assess the safety, tolerability and pharmacokinetics of additional repeat doses of epelsiban in healthy females, and will be the first dosing experience of greater than 200 milligram (mg) as a single dose with this compound. Data from this study will inform the selection of doses of epelsiban to be used in future clinical studies. This study will be composed of 3 periods: Screening, Treatment, and Follow-up. The total duration that a subject involved in the study will be up to 6 weeks. At least 2 cohorts of subjects will be enrolled in this study and cohorts will be conducted sequentially. Additional cohorts will be enrolled if determined necessary. A sufficient number of subjects will be screened for the study to obtain approximately 6 evaluable subjects per cohort.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02257359
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date December 18, 2014
Completion date January 29, 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03642665 - Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer Phase 4
Completed NCT01919502 - Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment N/A
Completed NCT03292770 - Mucus Removal Before Embryo Transfer N/A
Recruiting NCT06134609 - Does Sexual Intercourse Affect the Outcomes of Frozen-thawed Embryo Transfer? N/A
Completed NCT03040830 - Effect of Timing Progesterone Luteal Support on Embryo Transfer Phase 4
Recruiting NCT04725864 - Progesterone as Luteal Support in Frozen IVF Natural Cycles Phase 4
Recruiting NCT04619524 - Biomarkers of Endometrial Receptivity N/A
Completed NCT04297553 - Fresh Versus Freeze-only After CAPA IVM on PCOS Patients N/A
Completed NCT01846403 - Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting N/A
Completed NCT02703181 - Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers Phase 1
Recruiting NCT02825290 - Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study Phase 4
Completed NCT01863680 - Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel Phase 3
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Recruiting NCT04124913 - Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Phase 4
Completed NCT05364528 - Pregnancy Rate in Direct Versus Afterload Technique of Embryo Transfer
Completed NCT03581422 - Natural Cycles With Spontaneous Versus Induced Ovulation in FET
Completed NCT04253470 - Debate on Progesterone Elevation on the Day of Triggering
Not yet recruiting NCT06084793 - Music for Anxiety in Embryo Transfers N/A
Completed NCT03201783 - Immediate Versus Delayed FET Following a Stimulated IVF Cycle N/A
Recruiting NCT03518528 - Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer